NAITO & CO., LTD.

Other languages Naito & Co., Ltd.

Equities

7624

JP3641350008

Delayed Japan Exchange Other stock markets 01:56:34 16/05/2024 BST			5-day change	1st Jan Change
147 ^JPY	0.00%		0.00%	+2.82%

2023	Eisai to launch Alzheimer's drug Leqembi in Japan on Dec 20	RE
2023	Toshiba, Rohm to Invest $2.69 Billion to Make Power Devices in Boost to Japan Chip Industry	DJ

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Eisai to launch Alzheimer's drug Leqembi in Japan on Dec 20	12-13
Mori unveils Tokyo's tallest office tower, testing post-COVID demand	08/08/23
Biogen : approbation de la FDA pour la maladie d'Alzheimer	07/07/23
Naito & Co., Ltd. Reports Earnings Results for the Full Year Ended February 28, 2023	28/03/23
High Inflation Makes Japanese Stocks Bleed Losses; Toshiba Rises 2% as Bidder Moves Closer to Securing Buyout Funding	23/12/22
Traitement expérimental prometteur de Biogen et Eisai contre la maladie d'Alzheimer	28/09/22
Traitement expérimental prometteur de Biogen et Eisai contre la maladie d'Alzheimer	28/09/22
Alzheimer's drug study yields positive results, say makers Eisai and Biogen	28/09/22
Eisai to receive royalties instead of profits from Alzheimer's drug Aduhelm	15/03/22
Tokyo termine en retrait en attendant l'inflation américaine	09/06/21
Tokyo toujours attentiste avant l'inflation américaine	09/06/21
EN DIRECT DES MARCHES : L'Oréal, Airbus, Eurofins Scientific, Crédit Agricole, Walmart, Valneva...	23/12/20
Un plan ou pas de plan sous le sapin ?	23/12/20

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer